Information  X 
Enter a valid email address

Consort Medical Plc (CSRT)

  Print      Mail a friend       Annual reports

Thursday 12 July, 2018

Consort Medical Plc

Rule 2.9 Announcement

RNS Number : 5156U
Consort Medical PLC
12 July 2018
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

 

For immediate release

12 July 2018

 

Consort Medical plc

 

("Consort" or the "Company")

 

Rule 2.9 Announcement

 

In accordance with Rule 2.9 of the Code, Consort confirms that it has today issued 367 shares and therefore, as at the date of this announcement, it has issued share capital consisting of 49,288,618 ordinary shares of 10 pence each. 

 

The increase in issued share capital is the result of Consort share options being exercised by certain former employees. The shares issued upon exercise of the options were admitted for trading on the Main Market of the London Stock Exchange as part of the block admission update announced on 27 June 2013.

 

There are no ordinary shares held in treasury.  The ordinary shares trade on the Main Market of the London Stock Exchange.  The International Securities Identification Number (ISIN) of the ordinary shares is GB0000946276.

 

The Company has an American Depositary Receipt ("ADR") programme for which The Bank of New York Mellon acts as depositary. One ADR represents one ordinary share in the Company, with ISIN US21030P1049. The ADRs trade in the over-the-counter market in the United States and are not listed on any national US securities exchange.

 

Enquiries:

 

Consort Medical plc


+44 (0) 1442 867 920

Jonathan Glenn - Chief Executive Officer



Paul Hayes - Chief Financial Officer



 

Disclosure Requirements of the Code

 

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified.

 

An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s).  An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 p.m. (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 p.m. (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified.  Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror.  A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8.  A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 p.m. (London time) on the business day following the date of the relevant dealing.

 

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

 

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified.  If you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure, you should contact the Panel's Market Surveillance Unit on +44 (0) 207 638 0129.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
RTTRTMFTMBJBBTP

a d v e r t i s e m e n t